ATE249232T1 - Tanacetum parthenium extrakt - Google Patents

Tanacetum parthenium extrakt

Info

Publication number
ATE249232T1
ATE249232T1 AT00940292T AT00940292T ATE249232T1 AT E249232 T1 ATE249232 T1 AT E249232T1 AT 00940292 T AT00940292 T AT 00940292T AT 00940292 T AT00940292 T AT 00940292T AT E249232 T1 ATE249232 T1 AT E249232T1
Authority
AT
Austria
Prior art keywords
tanacetum parthenium
parthenium extract
extracts
reduced
extract
Prior art date
Application number
AT00940292T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11383110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE249232(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE249232T1 publication Critical patent/ATE249232T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Massaging Devices (AREA)
  • Adornments (AREA)
  • Cosmetics (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Air Bags (AREA)
  • Luminescent Compositions (AREA)
AT00940292T 1999-06-03 2000-05-31 Tanacetum parthenium extrakt ATE249232T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001244A IT1312342B1 (it) 1999-06-03 1999-06-03 Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
PCT/EP2000/004976 WO2000074695A2 (en) 1999-06-03 2000-05-31 Tanacetum parthenium extract

Publications (1)

Publication Number Publication Date
ATE249232T1 true ATE249232T1 (de) 2003-09-15

Family

ID=11383110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00940292T ATE249232T1 (de) 1999-06-03 2000-05-31 Tanacetum parthenium extrakt

Country Status (22)

Country Link
US (2) US6224875B1 (de)
EP (1) EP1181030B1 (de)
JP (1) JP4712258B2 (de)
KR (1) KR100727121B1 (de)
CN (1) CN1265814C (de)
AT (1) ATE249232T1 (de)
AU (1) AU769365B2 (de)
CA (1) CA2375910C (de)
CZ (1) CZ301703B6 (de)
DE (1) DE60005174T2 (de)
DK (1) DK1181030T3 (de)
ES (1) ES2206251T3 (de)
HK (1) HK1046245B (de)
HU (1) HU228799B1 (de)
IL (2) IL146841A0 (de)
IT (1) IT1312342B1 (de)
NO (1) NO328245B1 (de)
PL (1) PL197514B1 (de)
PT (1) PT1181030E (de)
RU (1) RU2241475C2 (de)
SK (1) SK285014B6 (de)
WO (1) WO2000074695A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
CN100539984C (zh) * 2001-03-16 2009-09-16 强生消费者公司 含有小白菊提取物的组合物及其用途
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
CN102309573B (zh) * 2003-09-12 2013-11-20 捷通国际有限公司 细胞因子调节剂及相关用法
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US7537791B2 (en) * 2006-02-21 2009-05-26 Integrated Botanical Technologies, Llc Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production
AU2013201510B2 (en) * 2006-02-21 2015-07-16 Isp Investments Inc. Parthenolide Free Bioactive Ingredients from Feverfew (Tanacetum Parthenium) and Processes for their Production
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
EP2542209A1 (de) 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Hautpflegezusammensetzung mit erwünschter farbe in loser form
CN103524520B (zh) * 2013-09-25 2015-12-09 中国人民解放军第四军医大学 一种从植物原料中提取小白菊内酯的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
RU2048804C1 (ru) * 1991-04-22 1995-11-27 Аслан Хангиреевич Агиров Шампунь для борьбы с педикулезом
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
FR2695931B1 (fr) 1992-09-24 1994-10-28 Madeca Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine.
ES2239010T3 (es) * 1999-06-03 2005-09-16 JOHNSON & JOHNSON CONSUMER FRANCE SAS Extractos de chrysanthemum matricaire (tanacetum parthenium) utilizados contra los trastornos inflamatorios.

Also Published As

Publication number Publication date
IL146841A (en) 2006-12-31
NO328245B1 (no) 2010-01-18
PL197514B1 (pl) 2008-04-30
PL352107A1 (en) 2003-07-28
HUP0201258A2 (en) 2002-08-28
EP1181030A2 (de) 2002-02-27
US6224875B1 (en) 2001-05-01
HUP0201258A3 (en) 2007-10-29
DK1181030T3 (da) 2004-01-26
WO2000074695A3 (en) 2001-05-03
AU769365B2 (en) 2004-01-22
NO20015867D0 (no) 2001-11-30
DE60005174T2 (de) 2004-07-15
ES2206251T3 (es) 2004-05-16
RU2241475C2 (ru) 2004-12-10
EP1181030B1 (de) 2003-09-10
JP2003501392A (ja) 2003-01-14
HU228799B1 (en) 2013-05-28
HK1046245B (zh) 2007-02-23
ITMI991244A0 (it) 1999-06-03
KR100727121B1 (ko) 2007-06-12
KR20020019452A (ko) 2002-03-12
CZ301703B6 (cs) 2010-06-02
JP4712258B2 (ja) 2011-06-29
DE60005174D1 (de) 2003-10-16
SK285014B6 (sk) 2006-04-06
CA2375910A1 (en) 2000-12-14
HK1046245A1 (zh) 2003-01-03
NO20015867L (no) 2001-11-30
US6479080B2 (en) 2002-11-12
CZ20014304A3 (cs) 2002-03-13
SK17482001A3 (sk) 2002-04-04
IT1312342B1 (it) 2002-04-15
WO2000074695A2 (en) 2000-12-14
ITMI991244A1 (it) 2000-12-03
CA2375910C (en) 2011-11-01
US20010021400A1 (en) 2001-09-13
CN1265814C (zh) 2006-07-26
IL146841A0 (en) 2002-07-25
PT1181030E (pt) 2003-12-31
AU5527200A (en) 2000-12-28
CN1353612A (zh) 2002-06-12

Similar Documents

Publication Publication Date Title
DE60005174D1 (de) Tanacetum parthenium extrakt
AU6205600A (en) Hydrophobic, high tg cycloaliphatic epoxy resins
AU2002218086A1 (en) Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent
WO2004108070A3 (en) Releasable polymeric conjugates based on aliphatic biodegradable linkers
WO2002094002A3 (en) Cultivated agarwood
AU3306900A (en) Crosslinkable coating compositions
FI964062L (fi) Epoksoituja, alhaisen viskositeetin omaavia, kumipitoisia sitkeytysmodifikaattoreita epoksihartseja varten
WO2004112703A3 (en) Interleukin-21 analogs
WO2005104722A3 (en) Crude extracts from andrographis paniculata
DE69816989D1 (de) Auf c5-verbindungen basierende, mit aromaten modifizierte harze
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
DE60304184D1 (de) Oberflächenpfropfmodifizierte harze und deren herstellung
ATE375013T1 (de) Radarkuppel mit niedrigem radarquerschnitt
FI970182A7 (fi) Epoksidoituja, alhaisen viskositeetin omaavia, kumin sitkeyttä modifio ivia aineita epoksihartseja varten
DE60000931D1 (de) Vernetzbare beschichtungszusammensetzungen
EP0970619A3 (de) Sossen- und Suppenkonzentrat
DE69728555D1 (de) Selbstdispergierende härtbare epoxidharze, damit hergestellte dispersionen und beschichtungszusammensetzungen
MXPA02012259A (es) Polimeros que estan modificados por medio de grupos funcionales.
DK1037642T3 (da) Modificerede polysaccharider med ændret biologisk genkendelse
EP1281887A3 (de) Rundlager
NO972531L (no) Nye membranproteiner p76 av Helicobacter pylori
CH694383A5 (de) Digitalmesslatte, insbesondere Digitalnivellierlatte.
MXPA03008758A (es) Preparacion de resinas funcionales de epoxi.
CA3273265A1 (en) Glycidyl ether modified amine sorbents, systems including sorbents, and methods using the sorbents
IL284547A (en) 3 balls with lighting and air conditioning

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1181030

Country of ref document: EP